HIMSS May 13, 2020
Ben Taylor, CEO and Founder, LedgerDomain; a HIMSS Blockchain in Healthcare Task Force Member

Under the Drug Supply Chain Security Act (DSCSA), the U.S. pharmaceutical supply chain will be brought together by an electronic, interoperable system to identify and trace prescription drugs as they’re distributed throughout the country. This has radical implications for the entire industry, as regulators and stakeholders all race the clock to transform how drugs reach the patients who need them.

In today’s drug supply chain, DSCSA-compliant verification is rare; but once it becomes required, without a real-time system that allows for single scans and near-instant verification, pharmacies will bear a massive regulatory burden.

To address these needs, a peer-reviewed study was commissioned in partnership with UCLA Health to deploy and test a last-mile blockchain-driven solution for caregivers to use in...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Blockchain, Pharma / Biotech, Supply Chain, Technology
AstraZeneca plans independent drug supply chains for US and China, CEO says
Vitality in the Supply Chain: The Limitless Potential of ATMPs
Red Sea Shipping Disruptions Don’t Have Pharma Companies Seeing Red Just Yet
Managing Uncertainties In Cell And Gene Therapy Supply Chain
Supply chain trends and challenges: Cell and gene therapies

Share This Article